Clinical Trials Browser

Phase 2/3 × cediranib × Gastrointestinal × Clear all

NCT00384176 2017-04-14

HORIZON III

Phase 2/3 Completed

1,814 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT00939848 2014-10-27

ABC-03

Phase 2/3 Completed

Gastrointestinal

Biliary Tract Neoplasms